Related Experiment Video

Updated: May 22, 2026

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
12:08

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Published on: May 22, 2013

The effect of silymarin on telomerase activity in the human leukemia cell line K562

Zohreh Faezizadeh1, Seyed Ali Reza Mesbah-Namin, Abdolamir Allameh

  • 1Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Planta Medica
|April 26, 2012
PubMed

Insights

Silymarin, derived from milk thistle, effectively inhibits cancer cell growth and telomerase activity in human leukemia cells. This suggests a new therapeutic approach targeting telomerase for leukemia treatment.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Telomerase is a potential target for cancer therapy.
  • Silymarin, from Silybum marianum, shows anticancer effects.
  • The impact of silymarin on telomerase in K562 leukemia cells is unknown.

Purpose of the Study:

  • To investigate silymarin's mechanism of action in K562 cells.
  • To determine silymarin's effect on telomerase activity.
  • To explore the link between silymarin, apoptosis, and telomerase.

Main Methods:

  • Cell proliferation assessed via MTT assay.
  • Apoptosis evaluated using Hoechst 33342 staining and flow cytometry.
  • Telomerase activity measured by telomeric repeat amplification protocol (TRAP)-ELISA.

Main Results:

  • Silymarin significantly inhibited K562 cell proliferation.
  • Silymarin treatment led to substantial reduction in telomerase activity.
  • A positive correlation observed between telomerase inhibition and apoptosis induction.

Conclusions:

  • Silymarin exhibits anticancer properties in K562 leukemia cells via telomerase inhibition.
  • This study reveals a novel anticancer mechanism for silymarin.
  • Findings support silymarin as a potential agent for anti-telomerase cancer therapies.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...